Ahmad S, Callan R, Cole JJ, Blagg CR
Effect of citrate-containing dialysate on dialyzer reuse
Am Soc Nephrol Ann Mtg -- Toronto
J Am Soc Nephrol
(Sep) 11:172A 2000

Dialyzer performance is mainly dependent on surface area and membrane
permeability,
both of which can be decreased by "clotting" of fibers and pores. One
indication of this is fiber bundle volume loss.
Recently a new
commercially available dialysate (DRYalysate, Advanced Renal Technologies,
Kirkland, WA) has been described (Ahmad et al, Am J Kid Dis, 35:493,2000).
Citrate in the dialysate was suggested to reduce fiber clotting accounting
for better dialysis dose associated with the DRYalysate.
In the present
study we compared dialyzer reuse in 29 patients over 8 to 24 months
(average 12.6 months) for 4,228 dialysis sessions using either regular
dialysate or DRYalysate. DRYalysate contained 2.4 mEq/l of citrate and 0.3
mEq/l of acetate; in comparison the regular (bicarbonate) dialysate
contained 4.0 mEq/L of acetate. All other constituents in both dialysates
were identical.
Both high flux (F-80 and F-60) and traditional
dialyzers (F-8, T-175, CA-HP110 and MCA180) were employed. At the
beginning of each regular or citrate dialysate test period, patients were
started on a new dialyzer. Reuse involved flushing with water, cleaning
with 2% sodium hypochlorite solution, and sterilization with 2%
formaldehyde and incubation at 40 degrees C. Dialyzers
were discarded if fiber bundle volume loss was >15% (in one dialysis
unit) and >20% (in two dialysis units). The reuse method and criteria
remained unchanged at each unit throughout the comparison periods. The
average number of uses on regular dialysate was 10.9 +/- 1.2 (mean +/-
SEM.).
On citrate dialysate, the number of dialyzer uses significantly
increased to 18.5 +/- 2.1 (p<0.0001)uses. These results indicate that
citrate dialysate reduces clotting of fibers, and enables a significantly
higher number of dialyzer re-uses.
Copyright 2000, American Society of Nephrology. Reproduced with
permission.